Detection of antigens in Alzheimer cerebrospinal fluid by monoclonal antibodies.
Monoclonal antibodies raised against cerebrospinal fluid (CSF) and human ventral forebrain from patients with Alzheimer's disease were tested against CSF pools derived from patients with Alzheimer's disease and normal controls. Antibodies that appeared to distinguish the two pools were subsequently tested against 58 CSF samples from individual Alzheimer patients, normal controls, and individuals with other neurologic diseases. The mean CSF content of two antigens was decreased in patients with Alzheimer's disease compared with controls; the mean CSF content of one of these antigens was also decreased in patients with other neurologic diseases. Although group differences could be detected, the degree of overlap did not follow for the separation of individual patients within these three groups.
Thal
L J
LJ
Department of Neurology, San Diego VA Medical Center, CA 92161.
Davies
P
P
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000134:cerebrospinal fluid*; D000941:Antigens / Q000134:cerebrospinal fluid*; D001921:Brain / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D051379:Mice
D000911:Antibodies, Monoclonal; D000941:Antigens